Thyroid Cancer

Thyroid Cancer Survivors May Have Increased Risk of Osteoporosis and Heart Conditions (March 3, 2017)

The results of a recent new study find that younger survivors of thyroid cancer are at increased risk for osteoporosis, high blood pressure and heart disease.  Thyroid cancer is the fifth most common... Continue Reading

Pass it On: It’s National Thyroid Awareness Month (September 8, 2016)

The thyroid gland is a butterfly-shaped organ that is below the Adam’s apple in the front part of the neck. It produces, stores, and releases hormones that regulate vital body functions. Thyroid cancer... Continue Reading

Complications Decrease with Surgeon Experience in Thyroidectomy (April 6, 2016)

Among patients undergoing the surgical removal of their thyroid, complications associated with the procedure are drastically reduced if surgeons perform a larger number of the surgeries per year. These... Continue Reading

National Thyroid Cancer Awareness Month on CancerConnect (September 8, 2015)

  As the month of September brings thyroid cancer into focus, it’s time to increase public understanding of the disease, including its prevalence, approaches to screening and prevention, treatment... Continue Reading

More Risk than Benefit with TSH Suppression in Thyroid Cancer without High Risk of Recurrence (May 21, 2015)

For patients undergoing treatment for thyroid cancer who aren’t at high risk of recurrence, therapy to suppress thyrotropin (TSH) may be ineffective as well as risky. These findings were published in... Continue Reading

Target Therapy Sutent® Promising in Advanced Thyroid Cancer (May 19, 2015)

The targeted therapy Sutent® (sunitinib) appears effective in the treatment of patients with advanced differentiated thyroid cancers. The Endocrine Society announced these Phase II trial findings in a... Continue Reading

Important Clues in the Development of Aggressive Thyroid Cancer (April 16, 2015)

New insight into how anaplastic thyroid cancer (ATC) grows and spreads may provide important direction in the development of treatment. These findings were published in the Journal of Clinical Endocrinology... Continue Reading

Lenvatinib; First Promising Treatment for Refractory Thyroid Cancer Patients in Years (March 3, 2015)

CancerConnect News: In a pivotal Phase III study published in the New England Journal of Medicine, the oral anti-angiogenic therapy lenvatinib appears to be a very promising new treatment for patients... Continue Reading

National Thyroid Cancer Awareness Month on CancerConnect (September 10, 2014)

Sun Valley, ID & Fort Worth, TX– OMNI Health Media (OMNI) announces the launch of educational programs for national thyroid cancer awareness month. As the month of September brings thyroid cancer... Continue Reading

OMNI-Connect Gets National Recognition as Valuable Social Media Solution in Medicine (August 13, 2014)

Fort Worth TX/Sun Valley ID – OMNI Health Media announces national recognition of its online support communities, TheGIConnection,TheRAConnection, and Cancer Connect, as valuable resources for... Continue Reading

Marriage May Have a Protective Effect for Cancer Patients (December 17, 2013)

Social support may have a significant impact on cancer detection, treatment, and survival, according to the results of a study published in the Journal of Clinical Oncology. The study showed that married... Continue Reading

Nexavar Approved for Metastatic Differentiated Thyroid Cancer (December 9, 2013)

The U.S. Food and Drug Administration (FDA) has approved Nexavar® (sorafenib) for the treatment of metastatic differentiated thyroid cancer. Differentiated thyroid cancer is the most common type of thyroid... Continue Reading

Mutations Linked to Drug Response in Medullary Thyroid Cancer (November 15, 2013)

Metastatic medullary thyroid cancers with certain genetic mutations respond better to treatment with Cometriq™ (cabozantinib) than tumors without those mutations, according to the results of a study... Continue Reading

TSH Suppression after Thyroidectomy May Not Be Beneficial (November 4, 2013)

Suppression of thyroid-stimulating hormone (TSH) after thyroidectomy for low-risk cancer does not appear to reduce the risk of cancer recurrence and may even increase the risk of osteoporosis in women,... Continue Reading

Summary News on Melanoma, Breast, Cervical, Ovarian, Prostate and Thyroid Cancer from Amer Soc Clinical Oncology Annual Meeting (October 1, 2013)

By Kari Bohlke, ScD Annual meeting brings together cancer experts from around the world. For thousands of oncology professionals and cancer researchers from around the world, the Annual Meeting of the... Continue Reading

End-of-Life Care Remains Aggressive, Despite Patient Wishes (September 16, 2013)

Although most patients with advanced cancer prefer hospice or palliative care that minimizes symptoms, many continue to receive aggressive treatment during their final weeks and months of life. In fact,... Continue Reading

Thyroid Ultrasound May Cut Biopsy Rate (September 13, 2013)

Thyroid ultrasound may help identify certain characteristics of thyroid nodules that can predict the likelihood of cancer—and subsequently help determine whether biopsy is necessary, according to the... Continue Reading

Understanding Osteonecrosis of the Jaw (August 30, 2013)

Cancer and its treatment can come with a variety of complications, some more serious than others. What Is Osteonecrosis of the Jaw? Osteonecrosis of the jaw (ONJ) is a severe bone disease that occurs when... Continue Reading

Next Page »

Sign up for the CancerConnect newsletter

Sign up for our newsletter and receive the latest news and updates about specific types of cancer.

  Close |  Please don't show me this again

Facebook Twitter RSS